ArticleInternational journal of colorectal disease2020

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events.

Vera E R Asscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.